Pall MPATHBRXPS0P0 iCELLis Nano Single-Use Fixed-Bed Bioreactor with mPath Controller

The Pall iCELLis Nano Single-Use Fixed-Bed Bioreactor with mPath Controller, manufactured in 2019, is designed to support high-density adherent cell culture critical in molecular diagnostics, gene editing, and biomanufacturing workflows. This compact fixed-bed bioreactor utilizes class VI polyester macrocarriers to provide an extensive surface area that optimizes cell attachment and growth, essential for biotechnology applications such as synthetic biology and biopharmaceutical production.

Key technical features include:

• A unique waterfall oxygenation system that enhances oxygen transfer efficiency while maintaining optimal cell viability.
• An integrated magnetic drive impeller that ensures uniform media circulation with low shear stress, safeguarding delicate adherent cells during bioprocessing.
• Single-use, disposable design reducing risk of cross-contamination and streamlining cleaning validation, which is critical for regulatory compliance in clinical diagnostics and bioprocess development.
• Compact footprint facilitating scalability from research & development to commercial manufacturing.
• Pre-packed macrocarriers for ease of setup and reproducible cell culture conditions.
• Operates on 240V, compatible with 50Hz/60Hz power supply, suitable for laboratory and industrial environments.

Weighing 21.77 kg (48 lbs) with shipping dimensions of 67.06 cm x 27.43 cm x 54.86 cm, this system is engineered for efficient use of laboratory space and integration into existing cell culture workflows. Its role in maintaining controlled temperature and environmental parameters is compliant with harmonized code 841989 for equipment involved in thermal processing of biological materials.

This bioreactor system is widely adopted in biotechnology and cell therapy research, providing a robust platform for bioprocessing applications including live-cell imaging, fluorescence analysis, and high-density cell culture necessary for molecular cloning workflows and large-scale biomanufacturing.